t:slim X2 Insulin PumpIt’s not just an insulin pump. It’s a life-changer.
Kids want a say when it comes to choosing how to manage their diabetes. We’ve made that choice easier for them and their parents.
The t:slim X2 insulin pump with Control‑IQ technology helps keep diabetes under control, offering more freedom for kids and greater peace of mind for their parents. Here are a few things to talk about when having a conversation about getting started with Control-IQ technology.
Flexibility to Disconnect
It’s easy to temporarily disconnect the t:slim X2 pump from an infusion set for showering or sports. Using data from Dexcom G6 continuous glucose monitoring (CGM),* kids can quickly see where they’re trending, and reconnect their pump in a snap.
A Predictive Algorithm
Control-IQ technology predicts glucose levels 30 minutes in advance and automates insulin dosing. It’s been shown to increase time in range, as measured by CGM, which means more time to just be a kid, and greater peace of mind for parents.
Rest Easier
The t:slim X2 pump with Control-IQ technology can turn insulin delivery on and off as often as every five minutes. This helps reduce the need to wake up at night to check numbers and correct a low, helping improve everyone’s nights and mornings.
Customize Profiles
Programmable profiles, as well as optional settings for Sleep Activity and Exercise Activity, let kids be kids. Plus, the t:slim X2 insulin pump fits easily into a small pocket or pouch to keep up with kids on the move.
Comfort of Control
Managing diabetes can feel like your brain is working overtime. Relax knowing that our insulin delivery system includes automatic correction boluses when needed, to help kids better control their diabetes.†
Technology You’re Used To
Our easy-to-use system feels a bit like a smartphone, with a colour touchscreen and software updates. The t:simulator app is a free, virtual pump demo that lets you test drive the touchscreen and pump interface.
More Time in Range
Average additional time in range per day for clinical study participants who used Control-IQ technology on the t:slim X2 insulin pump.1
More Sleep
Overnight sensor time in range for clinical study participants, aged 6-13, while using Control-IQ technology with the t:slim X2 pump.2
Don’t take our word for it!
Read inspirational and engaging stories from people who use the t:slim X2 insulin pump with Control-IQ technology on our Blog.
No Routine Fingersticks
No routine fingersticks required for dosing or calibration.‡
Security PIN
Protects kids from unintentional interactions on the t:slim X2 insulin pump.
Bolus Calculator
Enter carb values and let the pump do the math.
Download TodayFree Virtual Pump Demo
The t:simulator app lets you test drive the easy-to-use touchscreen interface of the t:slim X2 insulin pump and its predictive technologies using your smartphone.
Benefits of Pumping
Getting a new insulin pump can have a positive impact on managing your diabetes and your quality of life.
Choose from a variety of cannula materials, tubing lengths, and insertion angles to fit your needs.
We offer a wide range of accessories to personalize your insulin pump and match your unique lifestyle.
What's next?
Whether you're ready to get a Tandem insulin pump, or looking to check insurance coverage, you’ll find everything you need here.
* Dexcom CGM sold separately.
† Users must still bolus for meals and actively manage their diabetes. If glucose values are predicted to be above 10.0 mmol/L, Control-IQ technology calculates a correction bolus using the Personal Profile settings and a target of 6.1 mmol/L and delivers 60% of that value.
‡ No routine fingersticks required when using the t:slim X2 pump with Dexcom G6 CGM integration. If glucose alerts and CGM readings do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.
References
1. Brown SA, Kovatchev BP, Raghinaru D, et al. Six-month randomized, multicenter trial of closed-loop control in type 1 diabetes. N Engl J Med. 2019;381(18):1707-1717. doi:10.1056/NEJMoa1907863.
2. Breton MD, Kanapka L, Beck RW, et al. A randomized trial of closed-loop control in children with type 1 diabetes. N Engl J Med. 2020;383:836-845. doi: 10.1056/NEJMoa2004736.